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Abstract
The genus Salmonella contains two species, S. bongori and S. enterica. Compared to the well-studied S. enterica there is a
marked lack of information regarding the genetic makeup and diversity of S. bongori. S. bongori has been found predominantly
associated with cold-blooded animals, but it can infect humans. To define the phylogeny of this species, and compare it to S.
enterica, we have sequenced 28 isolates representing most of the known diversity of S. bongori. This cross-species analysis
allowed us to confidently differentiate ancestral functions from those acquired following speciation, which include both
metabolic and virulence-associated capacities. We show that, although S. bongori inherited a basic set of Salmonella common
virulence functions, it has subsequently elaborated on this in a different direction to S. enterica. It is an established feature of S.
enterica evolution that the acquisition of the type III secretion systems (T3SS-1 and T3SS-2) has been followed by the sequential
acquisition of genes encoding secreted targets, termed effectors proteins. We show that this is also true of S. bongori, which
has acquired an array of novel effector proteins (sboA-L). All but two of these effectors have no significant S. enterica
homologues and instead are highly similar to those found in enteropathogenic Escherichia coli (EPEC). Remarkably, SboH is
found to be a chimeric effector protein, encoded by a fusion of the T3SS-1 effector gene sopA and a gene highly similar to the
EPEC effector nleH from enteropathogenic E. coli. We demonstrate that representatives of these new effectors are translocated
and that SboH, similarly to NleH, blocks intrinsic apoptotic pathways while being targeted to the mitochondria by the SopA
part of the fusion. This work suggests that S. bongori has inherited the ancestral Salmonella virulence gene set, but has adapted
by incorporating virulence determinants that resemble those employed by EPEC.
Citation: Fookes M, Schroeder GN, Langridge GC, Blondel CJ, Mammina C, et al. (2011) Salmonella bongori Provides Insights into the Evolution of the
Salmonellae. PLoS Pathog 7(8): e1002191. doi:10.1371/journal.ppat.1002191
Editor: Howard Ochman, Yale University, United States of America
Received November 15, 2010; Accepted June 21, 2011; Published August 18, 2011
Copyright:  2011 Fookes et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: We thank the core sequencing and informatics teams at the Sanger Institute for their assistance and The Wellcome Trust for its support of the Sanger
Institute Pathogen Genomics and Biology groups and the MRC for their support of GF, KSR and GNS. MCF, GCL, TRC, HSS, GSV, MS, NKP, RAK, JP, GD and NRT were
supported by Wellcome Trust grant 076964 and MICROME, an EU Framework Programme 7 Collaborative Project, Grant Agreement Number 222886-2. Work was
also supported by Grant ADI-08/2006 from Comisio´n Nacional de Investigacio´n Cientı´fica y Tecnolo´gica (CONICYT) and The World Bank, and grant 1100092 from
Fondo Nacional de Desarrollo Cientı´fico y Tecnolo´gico (FONDECYT). CJB was supported by fellowships from CONICYT (21080373 and AT-24091015). The funders
had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nrt@sanger.ac.uk
" These authors have contributed equally to this manuscript and should be considered joint first.
Introduction
Salmonella serovars are predominately pathogenic Enterobacteriaceae
that are thought to have diverged from a common ancestor with
Escherichia coli ,100 million years ago [1]. The genus Salmonella
currently comprises two species; S. bongori and S. enterica, with S.
enterica being comprised of 6 subspecies enterica, salamae, arizonae,
diarizonae, houtenae and indica [2,3,4,5,6]. These S. enterica subspecies
are further subdivided into.2500 serovars. Although S. bongori have
been reported to infect humans [7,8], the species is predominantly
associated with cold-blooded animals whereas serovars causing
disease in humans and other warm-blooded animals mostly belong
to S. enterica subspecies enterica. Since S. enterica incorporates clinically
important pathogens, our knowledge about the genus Salmonella is
heavily biased and there is a marked paucity of information relating
to the genetic and phylogenetic makeup of S. bongori.
Even though E. coli and Salmonella are estimated to have
diverged millions of years ago, their genomes still display
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significant similarity including extensive regions of synteny.
However, in common with other Enterobacteriaceae significant
diversity has been driven by horizontal gene transfer on a
background of gradual genome sequence drift [9]. Many of the
genes which are unique to Salmonella serovars, compared to E. coli,
are found on large discrete genomic islands that include prophage
elements and specialised loci termed Salmonella pathogenicity
islands (SPIs) [10,11,12]. These Salmonella-specific functions
include many genes required for the full expression of virulence
and some of these were acquired by S. enterica following the split
from S. bongori. For example, S. enterica encodes two complete type
III secretion systems encoded by SPI-1 (T3SS-1) and SPI-2 (T3SS-
2) [13,14,15,16], whereas S. bongori lacks SPI-2, which is required
for optimal replication within macrophages [15,17,18].
Several characteristics of S. bongori suggest that this species may, in
evolutionary terms, lie somewhere between E. coli and S. enterica.
Consequently, to prove this hypothesis we have studied multiple
genotypic and phenotypic characteristics of S. bongori and compared
these to S. enterica and other Enterobacteriaceae. In terms of genotype,
we have determined a reference quality sequence of S. bongori 12419,
originally isolated from an African frog in 1972 (Salmonella
Reference Collection C strain SARC11) and prepared draft
sequences of a globally and temporally diverse S. bongori collection
including 21 representatives of the 23 known serovars (SV). From
our data we have been able to determine inter and intra-species
phylogeny and have used this to differentiate ancestral and more
recently acquired virulence and metabolic functions. These data
show that S. bongori possesses only a basic set of ancestral Salmonella
virulence functions and lacks several metabolic pathways that define
S. enterica. Nevertheless, S. bongori has not remained functionally
static; it has acquired a repertoire of 12 T3SS candidate effector
proteins, 10 of which are not found in other salmonellae but are
significantly similar to known effectors found in enteropathogenic
Escherichia coli (EPEC) strains. We herein demonstrate that
representatives of these effectors are translocated and that at least
one of these effectors, S. bongori outer protein H (SboH), is
functionally related to the non-LEE encoded EPEC effector NleH1.
Results
Phylogenetic analysis of the species S. bongori
To place S. bongori in the context of S. enterica we produced a
phylogenetic tree using the concatenated MLST gene sequences
(as described in [19]) from a selection of S. enterica Sequence types
(STs) covering all of the subspecies of S. enterica. The STs for S.
enterica were obtained from the S. enterica MLST website
(mlst.ucc.ie). The S. bongori MLST gene sequences were extracted
from our sequenced strains (described in Table S1), and the EPEC
MLST gene sequences were extracted from the genome sequence
of strain E2348/69 (Figure 1). Despite the spatial, temporal and
phenotypic diversity described within our collection, the S. bongori
species forms a surprisingly tight cluster of sequence types (STs)
clearly separated from the S. enterica subspecies (Figure 1). The S.
bongori isolates in our collection fall into 20 STs, which include 11
novel Salmonella STs (currently S. bongori-specific; Table S1). In
comparison, there were 1,419 STs identified as being part of S.
enterica present in the MLST database as of the 3rd of May 2011.
To investigate the diversity and population structure of S. bongori
we finished and fully annotated the genome of S. bongori 12419
(also known as SARC11 [20]). We then used this genome as a
reference to produce whole genome sequences for our collection of
27 further S. bongori isolates. Using the whole genome sequences we
produced a phylogenetic tree using RAxML (Figure 1), following
the removal of mobile genetic elements (MGE; regions excluded
from this analysis are listed in Table S2). In order to determine the
branch on which the root should be placed we also completed a
separate mapping including S. enterica subspecies arizonae strain
CDC346-86 (S. arizonae; EMBL CP000880) strain in order to
provide an outgroup. When using S. arizonae to locate the root for
the S. bongori tree at least three phylogenetic clusters are evident, a
feature that is supported by a clustering analysis performed using
the program Bayesian Analysis of Population Structure [21,22].
One of these clusters appears to be basal to the other clusters,
based on the position of the root. The clusters are separated by
15,948-22,398 SNPS (Figure S1). The level of SNP variation
between the clusters is consistent with the level of SNP variation
between two serovars of S. enterica. For example, 39,156 SNPs
differentiate S. enterica subspecies enterica serovar Typhimurium (S.
Typhimurium) strain SL1344 and S. enterica subspecies enterica
serovar Enteritidis (S. Enteritidis) strain P125109 (data not shown).
Within S. bongori serotype does not appear to provide a meaningful
indication of phylogenetic relationships within the population
(Figure 1). This feature of the dataset may imply that there is
frequent lateral gene transfer amongst S. bongori strains.
It is also apparent from the genomic data that there is a larger
difference in the shift in genome G+C content in S. enterica
following the divergence of the salmonellae, compared with S.
bongori (Figure S2). Considering S. enterica and S. bongori have been
evolving over the same time period these differences are
remarkable. Changes in G+C content over time are thought to
reflect subtle differences in mutational bias as a consequence of
different lifestyles [23]. The combined data in Figure 1 and Figure
S2 suggest that there has been a greater increase in G+C content
accompanying the specialisation of S. enterica subspecies into warm-
blooded hosts.
Genetic flux across the salmonellae
To obtain a comprehensive view of genetic flux over time we
used data from the other available Salmonella enterica genome
sequences, along with our 28 sequenced S. bongori isolates. To
complement this analysis, we used a pan-Salmonella microarray
[24], which included S. bongori-specific probes, to look at gene
presence/absence across the SARC collection where whole
genome sequences are lacking (see methods). First we focussed
our analysis on virulence functions that unified or distinguished S.
bongori from the other salmonellae (summarised in Figure 2).
Functions discussed below are conserved amongst all 28 S. bongori
Author Summary
The bacterial genus Salmonella consists of two species:
Salmonella enterica and Salmonella bongori. Salmonella are
common causes of food poisoning in humans and can also
cause more severe disease such as typhoid fever. Most of the
Salmonella that cause disease in humans and animals are
members of S. enterica. On the other hand S. bongori, is largely
associated with reptiles but can cause disease in humans,
albeit rarely. We have determined genomes for S. bongori
isolates representing its known diversity. Using this, and
existing genome information for a large number of different
members of S. enterica, we were able to identify functions
found in both species, and therefore likely to be ancestral, and
differentiate them from those that have been more recently
acquired. This information gives us more perspective on how
pathogens evolve over the longer-term and allows us to
identify functions that are associated exclusively with isolates
that commonly cause disease in humans. Our analysis
suggests that when S. bongori and S. enterica diverged they
evolved to occupy very different niches.
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strains we sequenced (unless otherwise stated) and are not isolate-
specific.
Salmonella pathogenicity islands
Of the 22 reported SPIs only SPI-1, SPI-4 and SPI-9 are present
in S. bongori 12419 with the same gene composition as those
defined in S. enterica (Summarised in Figure 2; Table 1). Consistent
with previous observations SPI-3 and SPI-5 are incomplete: SPI-3
exists as two independent insertions in S. bongori, SPI-3a and SPI-
3b, that appear to have fused into a single element in S. enterica
(Figure 2; This study; [25]). SPI-5 has previously been shown to be
a chimeric genomic island composed of two regions of markedly
differing G+C content in S. enterica, region one carrying the T3SS-
1 translocated effector genes sigE, sopB and pipD and region 2
encoding the T3SS-2 translocated effector gene pipB. S. bongori
possesses region 1 only; there is no trace of the T3SS-2 effector
gene encoded in region 2.
A significant distinguishing feature of S. bongori is the lack of SPI-
2 [14,18,26,27]. The site occupied by SPI-2 in S. enterica (alongside
tRNA-valV) carries a ,20 kb genomic island in S. bongori encoding
a novel type VI secretion system (SPI-22; see below). The
tetrathionate respiration (ttr) gene cluster which lies alongside
SPI-2 in S. enterica is retained by S. bongori.
All the T3SS-2 translocated effectors are absent from S. bongori
with the exception of SlrP, which in S. enterica subspecies is known
to be secreted by both T3SS-1 and T3SS-2 [28]. Conversely 10 of
the 12 known T3SS-1 translocated effectors are almost entirely
conserved between S. enterica subspecies and S. bongori and include
those that stimulate proinflammatory responses, bind actin and are
important for cellular invasion (sipA, sipB, sipC, sopB, sopD and
sopE2). S. bongori also carries effectors that dampen down
cytoskeletal rearrangements and host signalling responses by S.
enterica subspecies including avrA (reported to inhibit NF-kappa B
[29]) and sptP (pseudogene). Although the S. bongori sopA gene is
located at the same site as its orthologues within S. enterica it has
been disrupted by an insertion which has generated a chimeric
effector protein (denoted SboH; see below).
The S. bongori T3SS-1 translocated effector genes are found at
exactly the same genomic loci as they are in S. enterica: carried on
SPI-1 itself, SPI-5 or at identical sites in the chromosomal
backbone (Table 2). This suggests that most T3SS-1 effectors were
sequentially acquired prior to speciation, sopE and sspH1 being the
only exceptions. The latter two effector proteins are sporadically
distributed in S. enterica subspecies enterica isolates, and carried as
cargo on phage [30,31], consistent with them being more recent
acquisitions.
Figure 1. Maximum Likelihood Phylogenetic tree of Salmonella based on concatenated MLST loci. The relationships of the isolates shown
in the enlarged region were produced using a Maximum Likelihood phylogenetic tree of S. bongori based on the whole genome alignments
produced by mapping sequence reads to the reference genome S. bongori 12419 (see [82]). The location for the root for the tree for the enlarged
region was determined by using S. arizonae as an outgroup. The S. bongori isolates shown represent 21 different serotypes (SV), inferred by the
coloured circles, the tree branches are coloured by BAPS cluster (SNP counts for each branch and strain labels for each node are in Figure S1).
doi:10.1371/journal.ppat.1002191.g001
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In addition to the lack of SPI-2, S. bongori lacks the entirety of
SPI-6 (encoding a type VI secretion system), SPI-13 (required for
survival in chicken macrophages), SPI-14 (encoding an electron
transport system) and SPI-16 (bacteriophage remnant carrying
genes associated with LPS modification) making these islands
unique to S. enterica (This study;[10,32,33]). From the in silico
analysis and microarray data it is evident that SPI-6 and SPI-16
are present in all S. enterica lineages whilst SPI-13 and SPI-14 are
only sporadically distributed in S. enterica (Table 1; This study
[33,34,35]). S. bongori also lacks part of the centisome 54 island
(CS54) encoding shdB ratC and ratB which are associated with
survival in macrophages and longterm shedding of bacteria from
the host [36].
SPI-22: a novel SPI encoding a Type VI secretion system
(T6SS)
There are four distinct T6SSs currently described for Salmonella,
encoded on SPI-6, SPI-19, SPI-20 and SPI-21 [37,38]. S. bongori
lacks all four systems but carries a novel T6SS locus (,20 kb in
size) which we have denoted SPI-22 (Figure 3A). The T6SS genes
carried on SPI-22 shares extensive similarity to the recently
identified CTS2 T6SS locus of Citrobacter rodentium ICC168 [39]
and the HSI-III locus of Pseudomonas aeruginosa strain PA01 known
to be required for virulence (Figures 3B & 3C) [40]. SPI-22
encodes all of the core T6SS components including homologues of
DotU and IcmF, necessary for secretion and membrane
stabilisation of the T6SS apparatus, the ATPase ClpV, thought
to provide energy to the system, as well as other essential functions
associated with the T6SS apparatus including VgrG, Hcp and the
Gp25-like protein (Figure 3A)[41,42].
Novel T3SS effector proteins encoded by S. bongori
Apparently in contrast to S. enterica, in the absence of SPI-2 S.
bongori has significantly expanded its repertoire of T3SS-1 effector
proteins. Most of these candidate effectors are novel within
Salmonella but are related to non-locus of enterocyte effacement
(LEE) encoded (Nle) effector proteins found in EPEC, enterohe-
morrhagic E. coli (EHEC) or C. rodentium [39,43]. These three
enteric pathogens have a related infection strategy as they colonize
the intestinal mucosa while causing attaching and effacing (A/E)
lesions (reviewed by [44]). Of the 12 candidate T3SS-1 effector
proteins of S. bongori, SboD, SboE, SboF and SboG show
significant sequence similarity to NleI/G (Table 3)[45]. In addition
SboC shares 57% amino acid identity with EspJ [46]. Only sboD
Figure 2. Events in the evolutionary history of Salmonella bongori and S. Typhi, a phenotypically and evolutionarily distant member
of S. enterica. Traits shared by the common ancestor are depicted in blue; those unique to S. bongori are shown in red and those unique to S. Typhi
in green. Arrows, Salmonella Pathogenicity Islands (SPIs); extended ovals, fimbriae; circles, effectors; small ovals and needle complexes, secretion
systems. Metabolic pathways: lines, enzymatic reactions; open squares, carbohydrates; ovals, pyrimidines; open circles, other substrates; filled shapes,
phosphorylated. Novel effectors acquired by S. bongori are secreted by the type III secretion system encoded on SPI-1. SPI-3a and 3b carry the same
genes in both organisms but are fused into one island in S. Typhi. SPI-5a also carries the same genes in both organisms, but a further 3 kb (termed
SPI-5b) has fused to SPI-5a in S. Typhi. *indicates a pseudogene.
doi:10.1371/journal.ppat.1002191.g002
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and sboC genes have homologues in S. enterica subspecies: sboD is
similar to an uncharacterized gene, STY1076, that is carried as
‘cargo’ on the S. Typhi prophage 10 [10,47] and SboC shares 77%
amino acid identity with the predicted product of SARI_00261,
present at the same locus in S. arizonae.
S. bongori also harbours the first recognized Salmonella chimeric
T3SS effector gene, sboH; a fusion of the 59 450 bps of Salmonella
sopA to the 39 828 bps of a gene highly similar to the T3SS
effector nleH1 from EPEC, EHEC and C. rodentium (Figures S3
and S4). The sboH gene is found at the same locus as the S. enterica
sopA gene and so is likely to have been formed by the insertion
and partial deletion of sopA by an nleH1 homologue. By homology
the nleH1 portion of the gene is also incomplete, lacking the first
59 54 bps. The most obvious effect of this fusion is to replace the
cognate export signal of NleH1 (located in the N-terminal 19
amino acids [48]) with the export signal and InvB chaperone-
binding site of SopA (located in the N-terminal 45 amino acids
[49]) (Figure S3).
The loss of the sopA gene may be compensated for by the
presence of two other sopA-related CDSs (Table 3): the product
of sboA shares 89% amino acid identity over its full length with
SopA, including the export signal, the chaperone binding
domain, the invariant cysteine residue and other sites conserved
in the C-terminus of this family of proteins (Figure S5 [50]). The
sequence conservation between SboB and SopA is limited to the
N-terminal 130 amino acids (Figure S3). The remainder of the
sequence of SboB is weakly similar to a number of proteins of
unknown function from a range of organisms including: S.
enterica subsp. arizonae (SARI_00821) and S. enterica subsp. enterica
serovar Kentucky (SeKB_A1367: Genbank ABEI01000019),
other bacteria including Providencia and eukaryotic proteins
including a protein of unknown function from Naegleria gruberi
(Amoeba; 38.4% identity [79.1% similarity] in 211 amino acid
overlap).
The remaining candidate effectors include SboI, SboJ, SboK
and SboL, which all share similarity with leucine rich repeat
effectors from S. enterica, such as SlrP, as well as Ipa invasion
plasmid antigens from Shigella. Notably SboK is more similar to
leucine rich repeat (LRP) effectors found in Edwardsiella and
Yersinia spp. than SlrP.
As in many other enteric pathogens, all of the novel S. bongori
T3SS effector genes, except sboC, are found on intact or
degenerate prophage or regions unique to S. bongori compared to
other salmonellae. The exception being sboC which is found on a
backbone region conserved only in S. arizonae (Table 3).
Table 1. Distribution of known SPIs in the salmonellae.
In silico genome analysis Microarray data of S. enterica subspecies
SARC electrophoretic groups&
Genomic
Island
S. bongori
12419
S. Typhi
CT18
S. Typhimurium
LT2
S. Enteritidis
P125109
S. Gallinarum
287/91
S. Cholerasuis
SC-B67
II IIIa IIIb IV V VI VII
SPI-1 + + + + + + + + + + + + +
SPI-2 2 + + + + + + 2 + 2 V + 2
SPI-3 % + + + + + + V V V + + V
SPI-4 + + + + + + + 2 2 + + + +
SPI-5 £ + + + + + NFR NFR NFR NFR NFR NFR NFR
SPI-6 2 + + +Y +Y + V* V* V* V* 2 V* V*
SPI-7 2 + 2 2 2 2 2 2 2 2 2 2 2
SPI-8 2 + 2 2 2 2 2 2 2 2 2 2 2
SPI-9 + + + + + +Y + + + + + + V
SPI-10 2 + 2 +Y +Y 2 2 2 2 2 2 2 2
SPI-11 V V V V V + NFR NFR NFR NFR NFR NFR NFR
SPI-12 2 + + + + + V V V V V V V
SPI-13 2 2 + + + + 2 + + V 2 2 +
SPI-14 2 2 + + + + 2 + 2 + 2 2 +
SPI-15 2 + 2 2 2 2 2 2 2 2 2 2 2
SPI-16 2 + + + + V 2 2 2 2 2 2 2
SPI-17 2 + 2 + + 2 2 2 2 2 2 2 2
SPI-18 2 + 2 2 2 2 2 2 + 2 2 2 2
SPI-19 2 2 2 +Y + 2 + 2 2 2 2 2 2
SPI-20 2 2 2 2 2 2 NT + $ NT NT NT NT NT
SPI-21 2 2 2 2 2 2 NT + $ NT NT NT NT NT
SPI-22 + 2 2 2 2 2 2 2 2 2 2 2 2
+, all genes are conserved; -, entire SPI is missing; V, partially present; Y, pseudogenes are contained on SPI;
*saf BCD only; %, SPI-3 present as two independent genomic islands in S. bongori: SPI-3A and SPI-3B (see text for details); £, only half of this island is represented in S.
bongori (see text for details); NFR, detected but not fully represented on array; NT, not tested; $, taken from [37];
&taken from [20]; SARC electrophoretic groups (EG) relate to the following subspecies: S. enterica subsp. salamae - EG II; S. enterica subsp. arizonae - EG IIIa; S. enterica
subsp. diarizonae - EG IIIb; S. enterica subsp. houtenae - EG IV & VII; S. bongori - EG V; S. enterica subsp. indica - EG VI. Microarray data was submitted to ArrayExpress
under accession number E-TABM-931.
doi:10.1371/journal.ppat.1002191.t001
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Table 2. Distribution of type three secretion systems encoded by SPI-1 (T3SS-1) and SPI-2 (T3SS-2) and their secreted effectors in
the salmonellae.
Salmonella species
/serotypes
S.bongori
12419
S. Typhi
CT18
S.Typhimurim
LT2
S. Enteritidis
P125109
S. Gallinarum
287/91
S.Cholerasuis
SC-B67
S. arizonae
CDC346-86
Secretion
system
T3SS effector
systems
Presence
/absence
T3SS-1 + + + + + + +
T3SS-2 2 + + + + + +
T3SS effector
proteins
Genomic
Location
Secreted
by
Gene
name
Presence
/absence
øGifsy-1 SPI-2 gogB 2 2 + 2 2 + 2
SPI-5 SPI-2 pipB 2 + + + + + 2
ROD SPI-2 pipB2 2 + + + + Y + 2
BB SPI-2 sifA 2 + + + + + +
BB SPI-2 steA 2 + + + + + 2
BB SPI-2 sifB 2 + + + + Y + +
BB SPI-2 steB 2 2 + + + + 2
BB SPI-2 steC 2 + + + + + 2
BB SPI-1 & 2 slrP + + Y + + Y + Y + Y +
BB SPI-1 sopA 2* + Y + + + Y + Y 2
SPI-2 SPI-2 spiC (ssaB) 2 + + + + + +
SPI-5 SPI-1 sopB (sigD) + + + + + + +
BB SPI-1 sopD + + + + + + +
BB SPI-2 sopD2 2 + Y + + + + +
øSopE and øSE12 SPI-1 sopE 2 + 2 + + 2 2
BB SPI-1 sopE2 + + Y + + + + +
SPI-1 SPI-1 avrA + 2 + + + 2 2
SPI-1 SPI-1 sptP + Y + + + + + + Y
SPI-1 SPI-1 sipA (sspA) + + + + + + +
SPI-1 SPI-1 sipB (sspB) + + + + + + +
SPI-1 SPI-1 sipC (sspC) + + + + + + +
SPI-2 SPI-2 sseF 2 + + + + + +
SPI-2 SPI-2 sseG 2 + + + + + +
BB SPI-2 sseL 2 + + + + + +
øGifsy2 SPI-2 sseI (srfH) 2 2 + + 2 + Y +
BB SPI-2 sseJ 2 + Y + + + + +
ROD SPI-2 sseK1 2 2 + + + Y + +
ROD SPI-2 sseK2 2 2 + 2 2 2 2
øSE20 - sseK3 2 2 2& + 2 2 2
ROD SPI-1 & 2 sspHI 2 2 +@ 2 2 2 2
SPI-12 SPI-2 sspH2 2 + + + + Y + Y +
pSLT plasmid SPI-2 spvB 2 2 + + + 2 +
+, present; -, absent; Y, pseudogene;
*, see sboH: a chimera of sopA and a Non-LEE-encoded Type III secretion system effector gene nleH1; BB, chromosomal backbone; ROD, region of difference/genomic
island;
@, of limited distribution in S. Typhimurium [89]; &, carried on phage ST64B of other S. Typhimurium strains [90].
doi:10.1371/journal.ppat.1002191.t002
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Functional analysis of the novel S. bongori effector
proteins
To confirm that the candidate T3SS effector proteins could be
translocated we selected representatives of all the classes we
identified (Table 3) and performed a fluorescence-based ß-
lactamase translocation assay [51]. This confirmed that SboA
(SopA-like), SboH (SopA - NleH1 chimera), the EspJ homologue
SboC, the NleG-family effector SboD and the leucine rich repeat
effector SboI were all efficiently translocated into host cells in a
T3SS-1 dependent manner (Figure 4A). Translocation of the
effector SboI fused to four HA-tags (HAx4) was also visualized by
immunofluorescence microscopy of infected cells (Figure 4B). No
translocation was observed upon infection with S. bongori DinvA
expressing SboI-HAx4 or S. bongori wild type expressing the house-
keeping protein FabI fused to the HAx4-tag. FabI-HAx4 could be
detected inside a few bacteria, which was also sporadically
observed for SboI-HAx4 in wild type or DinvA strains (data not
shown). In contrast, upon infection with S. bongori wild type
expressing SboI-HAx4 the effector showed cytoplasmic distribu-
tion throughout strongly infected cells, and was also found
surrounding a fraction of the bacteria in a ring-like staining
pattern, reminiscent of a vacuolar membrane.
Since SboH is the first reported chimeric effector protein we
wanted to confirm its function. The EPEC effector NleH1 was
recently shown to inhibit apoptosis through a C-terminal interaction
with Bax inhibitor 1 [52]. In order to determine if SboH possessed
the anti-apoptotic activity of NleH1, we transfected HeLa cells with
pRK5-nleH1, pRK5-sboH or a control plasmid pEGFP-N1, treated
with the pro-apoptotic compounds tunicamycin (TUN) or brefeldin
A and quantified the number of transfected cells showing activation
of the apoptosis executioner caspase-3 by immunofluorescence
microscopy. SboH prevented activation of caspase-3 by both stimuli
as efficiently as NleH1 (Figure 5A & B).
The immunofluorescence analysis of transfected cells indicated
that NleH1 and SboH are targeted to different subcellular
locations (Figure 5A). Whereas NleH1 shows plasma membrane
and perinuclear localization, SboH seemed to localize in discrete
structures reminiscent of mitochondria. To substantiate this
observation we stained transfected cells with the mitochondrial
marker MitoTracker (Figure 5C). This demonstrated that SboH
almost exclusively co-localized with the mitochondria, whereas
NleH1 did not localize to the mitochondria.
To analyze the impact of SboH in S. bongori infection we
performed a cell detachment assay as described by Hemrajani
Figure 3. Salmonella bongori harbours a novel and phylogenetically distinct T6SS. A. Schematic representation of the SPI-22 T6SS locus.
Coding sequences are represented as blocked arrows showing the direction of their transcription. Conserved core T6SS components are represented
with a different color. B. DNA-based comparison of the T6SS encoded in SPI-22 and the CTS2 locus of Citrobacter rodentium strain ICC168. The
analysis was performed by TBLASTX with WebACT and visualized with ACT software. C. Evolutionary relationships of Salmonella T6SS loci. A distance
tree (neighbour-joining) was calculated from concatenated VipA and VipB protein sequences of previously identified T6SS gene clusters, including
the novel SPI-22 T6SS locus. Each of the four major phylogenetic groups is shown in the nodes labeled A to D. Bootstrap support values (% from
3,000 replicates) were: A, 99%; B, 80%; C, 99% and D, 99%. For brevity species or serovar names are used only.
doi:10.1371/journal.ppat.1002191.g003
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et al.[52]. This assay measures the loss of cells due to S. bongori
infection without discriminating specific cell signaling pathways.
The assay shows that a S. bongori DsboH mutant causes a moderate,
but significant increase of 15% in cell loss (p-value,0.001)
compared to S. bongori wild type (Figure 5D). Complementation of
the S. bongori DsboH mutant with SboH restored levels of cell
detachment to that of the wild-type.
Taken together, our data suggest that SboH combines features
of SopA, namely the mitochondrial targeting signal, with the
capability of NleH1 to inhibit tunicamycin and brefeldin A
induced apoptosis. During infection, most likely through its anti-
apoptotic activity, SboH reduces bacterial cytotoxicity and host
cell loss.
Metabolic functions mark the evolutionary divergence of
S. bongori and S. enterica
We used genome sequence data to explore the distribution of
metabolic pathways and their associated genes within the
Salmonella serovars. As direct comparisons of the metabolic maps
of S. Typhimurium and E. coli have been reported previously [53]
we focused our analysis on comparing S. bongori to other Salmonella
serovars building upon data from S. bongori 12419 (Figure 2).
Arguably one of the most distant comparisons we could make
across the salmonellae would be between S. bongori and the acutely
pathogenic, human restricted, S. enterica subspecies enterica serovar
Typhi (S. Typhi). Within this comparison we found a surprisingly
high degree of conservation. All of the thirty pathways known to
be involved in the generation of precursor metabolites and energy
for S. Typhi are present in S. bongori (Table S4). Of the 146
predicted biosynthetic pathways found in S. Typhi, including the
biosynthesis of amino acids, carbohydrates, fatty acids and lipids,
only 8 are missing from S. bongori. Equally, of the 78 degradative
pathways carried by S. Typhi, S. bongori shares 72 and possesses
only 3 unique pathways.
The unique S. bongori metabolic capabilities (compared to S.
Typhi) include the degradation of complex acid sugars D-
galacturonate and L-idonate, which are sporadically distributed
throughout the salmonellae. However, more restricted in its
distribution is the capacity to degrade lactose. S. bongori encodes b-
D-galactosidase (lacZ) and the lactose operon repressor (lacI) but is
missing lacY (the high affinity lactose permease) which explains
why although it is a non-lactose fermenter S. bongori gives a positive
result on ortho-nitrophenyl-b-D-galactopyranoside (ONPG) me-
dium. Most members of S. enterica subspecies enterica are
phenotypically non-lactose fermenters and are unable to utilise
ONPG. The only other salmonellae that appear to harbour the lac
operon include S. enterica subspecies arizonae and diarizonae, but
these subspecies also possess lacY. Comparing S. bongori to other
Enterobacteriaceae which are non-lactose fermenters but are ONPG
positive there is no strong conservation in genes or the site of
insertion, suggesting independent acquisition events [54,55].
There is also evidence of metabolic streamlining in S. bongori.
For example, like E. coli, S. bongori has lost the cob-pdu gene cluster
(S. bongori retains only fragments of the first and last gene of the cob-
pdu cluster: cobT [SBG__1882] and pduX [SBG_1882A]) and so
lacks the capacity to anaerobically synthesise vitamin B12
(cobalamine) and to catabolise propanediol [56]. The cob-pdu gene
cluster was thought to have been lost by many Enterobacteriaceae. It
has been suggested that the cob-pdu gene cluster was subsequently
reacquired by S. enterica, following its split from S. bongori
[57,58,59], where it has been shown to be important for survival
in macrophages [60] a niche in which S. bongori cannot survive
[61].
Conversely there is evidence that pathways conserved in S.
bongori, E. coli and wider Enterobacteriaceae, have been lost and
replaced in the warm blooded-host adapted serovars of S. enterica
subspecies enterica by alternative pathways that are energetically
more efficient producing more ATP/mol of substrate or have
differing substrate specificities.
S. bongori carries the same genes for L-tartrate or citrate
fermention as those found in E. coli and most other enterics: the
ttdABDT operon or citDEF. However, these have been either
replaced (only remnants of the ttd genes remain in members of
subspecies enterica e.g. S. Typhi strain CT18 position
3230063..3230191 and S. Enteritidis strain P125109, SEN3049A)
or, in the case of citrate, augmented in S. enterica subspecies enterica
Table 3. Novel candidate T3SS effector proteins.
Novel T3SS effector S. enterica subspecies and serovars
Genomic
Location
Gene
name
Protein
family
S. bongori
12419
S. Typhi
CT18
S. Typhimurium
LT2
S. Enteritidis
P125109
S. Gallinarum
287/91
S. Cholerasuis
SC-B67
S. arizonae
CDC346-86
BB sboH sopA-nleH1
chimera
SBG_1891 2 2 2 2 2 2
øSB100 sboA sopA SBG_0925 2 2 2 2 22 2
ROD sboB sopA SBG_0789 2 2 2 2 2 2
ROD sboC espJ SBG_2380 2 2 2 2 SARI_00261
ROD sboD nleI/G SBG_2043 STY1076 2 2 2 2 2
Degenerate ø sboE nleI/G SBG_0673Y 2 2 2 2 2 2
øSB100 sboF nleI/G SBG_0924 - 2 2 2 2 2
øSB101 sboG nleI/G SBG_0932 2 2 2 2 2 2
ROD sboI LRP SBG_1086 2 2 2 2 2 2
ROD sboJ LRP SBG_1076 2 2 2 2 2 2
ROD sboK LRP SBG_0970 2 2 2 2 2 2
ROD sboL LRP SBG_0969 2 2 2 2 2 2
LRP, leucine rich repeat protein, BB chromosomal backbone; ROD region of difference/genomic island; propgace. Y, pseudogene.
doi:10.1371/journal.ppat.1002191.t003
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Figure 4. S. bongori translocates five novel effector proteins into the host cell. A. The translocation of TEM1-fusions of the putative new
effectors, the positive controls SopB and SopD, and the negative control FabI into HeLa cells by S. bongori wild type (black bars) or the T3SS-deficient
mutant S. bongori DinvA (white bars) was measured using a Fluostar Optima plate reader. The translocation rate is expressed as fold increase of the
emission ratio 450/520 nm of each sample in relation to the emission ratio of uninfected cells. SboA-, SboC-, SboD-, SboH- and SboI-TEM1, along with
SopB- and SopD-TEM1, but not FabI-TEM1 were translocated into the host cell. Error bars represent mean standard deviation (SD). Similar results were
obtained in three independent experiments. B. The translocated effector SboI shows cytoplasmic distribution throughout strongly infected cells and
a ring-like staining around bacteria reminiscent of a vacuolar membrane. HeLa cells were infected with S. bongori wild type or DinvA expressing SboI
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by the acquisition of two operons encoding tartrate hydratase (e.g.
STM3350-3359) and a second citrate lyase gene cluster (e.g.
STM0052-STM0063). Both of these clusters carry a dedicated
Na+ translocating oxaloacetate decarboxylase to provide reducing
power. Therefore unlike the pathways found in S. bongori and E. coli
these new pathways do not require a co-substrate and are
energetically more efficient, producing more ATP/mol of
substrate [62,63,64]. Moreover mutations in these new gene
clusters in S. Typhimurium can be found as attenuating in genome
wide mouse mutagenesis studies [65] and our microarray analysis
of SARC shows that all other S. enterica subspecies resemble S.
bongori by possessing the ttd cluster but lacking the alternate tartrate
and citrate dissimilatory operons (data not shown). Looking more
broadly across the Enterobacteriaceae, some Klebsiella pnenumoniae
or FabI fused to four HA-tags (HAx4) for 2 h and processed for immunofluorescence microscopy (DNA - blue, HA-tag - green, LPS - red, actin - white).
Bar = 5 mm.
doi:10.1371/journal.ppat.1002191.g004
Figure 5. The chimeric effector SboH combines features of NleH1 and SopA and reduces host cell detachment during infection. A–C.
To compare the phenotypes of SboH and NleH1 HeLa cells were transfected with pRK5-nleH1, pRK5-sboH or the control plasmid pEGFP-N1 and
processed. A. SboH inhibits tunicamycin (TUN) and brefeldin A (BFA) induced caspase-3 activation. Immunofluorescence analysis of transfected HeLa
cells treated with 5 mg/mL TUN or 10 mg/mL BFA for 18 h and stained for DNA (blue), Myc-tagged effectors (green) and activated caspase-3 (red).
GFP, but not SboH and NleH1 expressing cells frequently stain positive for activated caspase-3. (Images are representative of both TUN and BFA
treated cells). Bar = 10 mm. B. The level of inhibition of caspase-3 activation by SboH or NleH1 was quantified by immunofluorescence counting of
transfected cells. C. SboH and NleH1 are targeted to different subcellular locations. Transfected HeLa cells were stained for DNA (blue), Myc-tagged
effector (green) and mitochondria (red) and analysed by immunofluorescence microscopy. SboH nearly exclusively co-localises with the
mitochondrial marker MitoTracker, whereas NleH1 shows plasma membrane and perinuclear localisation. Scale bar = 10 mm. D. Cells infected with S.
bongori DsboH show increased cell detachment. Quantification of HeLa cells lost following 5 h infection with S. bongori wild type, DinvA mutant,
DsboH mutant and DsboH pSboH complemented strain. Staurosporine (STS) was used as a positive control to induce cell detachment. The one-way
ANOVA Test using Bonferroni correction was used on data from five independent experiments and showed that the differences between S. bongori
wild type and DsboH, as well as between S. bongori DsboH and the complemented strain are significant (* p-value,0.001). There was no significant
difference between S. bongori wild type and the complemented strain (# p-value .0.05).
doi:10.1371/journal.ppat.1002191.g005
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isolates also possesses a related second citrate lyase, sometimes
located at the same site in the genome as that found in S. enterica
subspecies enterica serovars. However, the gene makeup of this
region in K. pnenumoniae differs slightly and we could not find this
region at this site in other enterics we searched consistent with this
region being sporadically acquired.
There are other examples of lineage-specific metabolic
streamlining which show a more sporadic phylogenetic distribu-
tion including the C-P lyase system (phnA-P), able to breakdown a
wide range of phosphonate compounds, and phosphonatase which
is specific for 2-aminoethylphosphonate. Whilst S. enterica subspe-
cies arizonae carries the entire cluster (data not shown) the S. bongori
phn loci is degenerate, consisting of only phnOAB and remnants of
phnP and phnN (SBG_3727 and SBG_3728A, respectively).
S. enterica subspecies enterica has also lost the majority of genes in
this operon leaving only phnOAB [66], but have acquired the
phosphonatase system encoded by phnVUTSRWX [66]. The
explanation for this replacement in members of subspecies enterica
may lie in that fact that 2-aminoethylphosphonate is found in
abundance in flagellates found in the digestive tracts of ruminants
such as cattle, common hosts for members of subspecies enterica
[67]. Our microarray data for this cluster also shows that genes
phnVUTSRWX are only present in S. enterica subspecies enterica (data
not shown).
The capacity to use allantoin as a sole nitrogen source under
anaerobic conditions is also phylogenetically restricted. We have
previously speculated that the acquisition of the allantoin gene
cluster by S. enterica subsp. enterica was linked to differences in the
sequential breakdown of purines by different hosts [68,69]: in fish,
crustaceans and other invertebrates purines are broken down
sequentially to ammonia and CO2 [70,71], while genetic lesions in
vertebrate species block purine catabolism at different steps
leading to the accumulation of allantoin in most mammals
(including rodents and domesticated animals). Our current data
shows that the genes encoding allantoin degradation in Salmonella
are absent from S. bongori and restricted to S. enterica subspecies
enterica and salamae only.
Discussion
Our understanding of Salmonella evolution has been built largely
on data from representative isolates of the relatively recently
emerged Salmonella enterica subspecies enterica. S. bongori and S.
enterica are thought to have diverged between 40-63.4 Myrs ago
[72] and so comparing the genomes of these two distinct species
provides a unique opportunity to understand the ancestral
Salmonella and determine the evolutionary events that mark
speciation and those that track different branch points in Salmonella
evolution following this event.
We have shown that a diverse set of S. bongori isolates form a
tight cluster of sequence types that, when examined on a whole
genome basis, appear to comprise at least three phylogenetic
groups. The G+C content in S. bongori represents a midpoint
between S. enterica subspecies enterica and E. coli (Figure S2), but the
phylogenetic analysis with MLST data and whole genome
sequences suggests that this may be an artifact of the host
specialisation into warm blooded animals that took place in the
evolution of S. enterica subspecies enterica. The variation across the S.
bongori species, both within and between the phylogenetic groups,
contrasts sharply with that observed across S. enterica, with a
comparable amount of variation across the groups in S. bongori, to
that which is found between two serotypes of S. enterica subspecies
enterica. The apparent lack of variation is difficult to explain since
even if S. bongori had been stably maintained for a long period
within its current niche significant genome diversity would still be
expected, even if this was largely neutral. This reduced level of
apparent diversity could be a bias of sampling, yet the isolates
sequenced in this study are from a wide range of sources and are
globally and temporally diverse. Although the answer to this
question is still equivocal it is possible that S. bongori has been
through a recent evolutionary bottleneck.
Despite their apparent evolutionary divergence, metabolic
analysis showed that the biochemical maps of S. bongori and S.
Typhi are very similar, suggesting that Salmonella serovars acquired
many of the basic functions for an enteric lifestyle early in their
evolution. This has been recently supported by the finding that the
ability to use tetrathionate as an electron acceptor provides a
competitive advantage to S. Typhimurium in the inflamed gut
over normal flora [73]. The ttr cluster is conserved in S. bongori
[74].
Where S. bongori did differ from S. enterica serovars, it generally
most closely resembled E. coli and the wider Enterobacteriaceae, i.e.
the presumed ancestral state. Whilst the independent acquisition
of the lac operon by S. bongori is difficult to explain, for E. coli the
acquisition of the lac operon may have facilitated metabolism of
milk sugar and adaptation to the mammalian gut. Conversely the
loss of this function from S. enterica subspecies enterica may be
associated with its invasive lifestyle since recent evidence has
shown that lacI expression interferes with the function of SPI-2 and
attenuates virulence in macrophage [75].
This comparative analysis also highlighted metabolic traits that
mark the evolution of S. enterica subspecies enterica including the
differing abilities to ferment L-tartrate and citrate. These
metabolic differences are already known to differentiate high
and low pathogenicity Salmonella strains (S. Paratyphi B and S.
Paratyphi B variant Java) [76]. Outside of Salmonella the ability to
ferment citrate almost equally divides clinical Klebsiella pneumoniae
biotypes into two groups and is thought to represent an adaptation
to different nutrient conditions found within the host [77].
S. bongori possess a basic Salmonella virulence ‘tool kit’ consisting
of SPI-1, 3a, 3b, 4, 5 and 9. Although the S. bongori SPI-3 and SPI-
5 have a different structure compared to those in S. enterica these
SPIs are conserved across the salmonellae and could be considered
part of the Salmonella core genome. Moreover, many of these core
SPIs show significant regulatory and functional interplay between
the functions they encode. For example the SPI-4 adhesin SiiE is
required for efficient translocation of T3SS-1 effectors in S.
Typhimurium [78] and SPI-4, SPI-5 and SPI-1 genes are under
joint control by the SirA/HilA global regulatory cascade
[78,79,80,81]. From this it is tempting to speculate that these
SPIs define one of the earliest virulence networks of Salmonella.
Clearly there are multiple factors missing from S. bongori which
limit its ability to cause disease in warm blooded animals
demonstrated by experiments that have introduced SPI-2 into S.
bongori [61].
The genome of S. bongori has not remained static since
divergence; we see parallels with S. enterica serovars in the functions
that have been acquired following divergence. For example both S.
bongori and S. enterica have independently acquired different T6SSs.
It is clear that the Salmonella genus as a whole includes
representatives of each of the major T6SS phylogenetic groups,
thus reinforcing the long-term importance of these systems. Also
like S. enterica, S. bongori has sequentially acquired a range of T3SS-
1 effector proteins many of which we have shown to be
translocated. The S. bongori effectors have homologues in EPEC,
EHEC and C. rodentium including EspJ; which in EPEC and EHEC
prevents receptor mediated phagocytosis of opsonised cells [46]
and so could be important for S. bongori in resisting phagocytosis.
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This strategy would be well in line with previous observations of
the S. bongori life style as the bacteria are not able to sustain an
intracellular life style in macrophages mainly due to absence of the
SPI-2 T3SS-2 and its effectors [61] and likely also because of the
lack of cob-pdu operon too [60]. We also functionally characterised
the effector SboH and have shown that it inhibits apoptosis in a
similar manner to its EPEC homologue NleH1. Moreover, in
infection SboH reduces bacterial cytotoxicity. In EPEC the anti-
apoptotic activity of NleH1 has been proposed to sustain
colonisation of the mucosal epithelium by reducing the ‘turn-
over’ of surface enterocytes and associated any bacteria or
microcolonies [52]. The acquisition of these effectors that most
closely resemble those from pathogenic E. coli strains causing
watery diarrhea suggests that following the split of S. bongori and S.
enterica, S. bongori has adopted a specialised infection strategy which
might in parts be more similar to the extracellular pathogenic E.
coli than S. enterica. This infection strategy might be optimised to
colonise cold-blooded reptiles, but still provides the basic armoury
for S. bongori to emerge as an opportunistic pathogen of humans
and animals.
Materials and Methods
Source and details of bacterial strains
The S. bongori exploited in this study included 28 isolates
originating from between 1966-2004, from the USA, Africa and
Europe, from hosts including humans, frogs, pigeons and reptiles
as well as environmental sources including the shell of a hen’s egg,
cheese, fishmeal and waste water (see Table S1).
Genome sequencing assembly, mapping and phylogeny
For bacterial cultures LB medium was inoculated and grown
overnight at 37uC with each isolate. Genomic DNA was extracted
from 1 ml of culture by using manufacturer’s instructions (Wizard
Genomic DNA Purification kit from Promega).
The genome of S. bongori strain 12419 was sequenced to
approximately 11-fold coverage from pUC19 (insert size 2.8–
5.5 kb) and pMAQ1b_SmaI (insert size 5.5–6.0 kb) genomic
shotgun libraries using big-dye terminator chemistry on
ABI3700 automated sequencers. End sequences from large insert
BAC libraries in pBACe3.6 (insert size 23–48 kb) were used as a
scaffold. All repeat regions were bridged by read-pairs or end-
sequenced polymerase chain reaction (PCR) products.
For all remaining S. bongori strains, tagged genomic library
preparation and DNA sequencing (with and without multiplexing)
was carried out as previously described [82]. Mapping of reads to
the reference genome and SNP detection were carried out
according to earlier described protocols [82]. De novo assemblies
were performed by using Velvet v0.7.03 and their corresponding
contigs were ordered using Abacas [82]; the resulting pseudomo-
lecules were blasted against the reference genome to assess synteny
as well as the existence of indels and novel regions. Details of
mapping and assembly data output are given in Table S1.
Annotation and analysis was performed using Artemis and ACT
[83,84].
Phylogenic analysis of Salmonella (shown in Figure 1) was based
on the 7 concatenated MLST loci sequences, from sequences
generated in this study (for the S. bongori isolates), those obtained
from the Salmonella MLST Public Strains Database (http://mlst.
ucc.ie/mlst/dbs/Senterica for the S. enterica STs) or obtained from
genomic sequence (for EPEC strain E2348/69 [43]). The S. bongori
tree was produced using a whole genome alignment generated by
mapping the S. bongori samples against the finished genome of
strain 12419. Trees were drawn using RAxML assuming a general
time reversible site model with gamma correction [85]. In the case
of the whole genome tree, phage and MGEs were removed prior
to the production of the tree (see Table S2). Support for nodes was
assessed by using bootstrapping (x100); SNPs were reconstructed
on the tree with parsimony using accelerated transformation.
BAPS analysis was performed on the SNP alignments produced
from the mapping alignment, using the BAPS individual mixture
model [22]. Three independent iterations of BAPS were
performed (using an upper limit for the number of populations
of 25, 26 and 27) to obtain the most optimal partitioning of the
sample.
Defining orthologous gene-sets
To infer the orthologous genes in each pair of genomes
compared: Each CDS (a) from the genome (A) was searched, using
FASTA, against the CDSs of the other genome (B). If the top hit
covered at least 80% of the length of both sequences with at least
30% identity, a reciprocal FASTA search of the top hit sequence
(b) was launched against the CDSs of the first genome. If the
reciprocal top hit was the same as the original query CDS then (a)
and (b) are considered orthologous genes of (A) and (B). In a
second step, in order to validate the results, we performed a
BLASTN and TBLASTX comparison between the 15 genomes,
visualized using ACT [83] to curate ambiguous cases, for example,
gene remnants (pseudogenes), IS elements and phage-related
CDSs, and to check for a syntenic relationship among the putative
orthologs.
Pathway Tools
A Pathway/Genome Database (PGDB) describing the meta-
bolic pathways of S. Typhi was created in Pathway Tools v. 13.5
(SRI International, California) using the genome sequence and
annotation associated with strain CT18 [10]. This PGDB
underwent manual curation and currently comprises 200 predict-
ed metabolic pathways and over 130 predicted transport reactions.
To determine the differences in S. bongori relative to S. Typhi, we
mapped orthologues onto the pathways and transport reactions,
subsequently removing those missing functions and adding in the
functions unique to S. bongori (summarised in Figure 2 and listed in
Table S4).
S. bongori deletion mutant and novel T3SS effector
plasmid construction
Primers, restriction enzymes and plasmids used to create S.
bongori deletion mutants and to construct expression vectors of the
putative S. bongori effector proteins are listed in Table S3.
Specific gene knockouts of the invA or sboH genes were
generated in S. bongori 12419 as described previously [86]. To
create non-polar mutations, the kanamycin resistance cassette was
removed using plasmid pCP20 leaving a scar of 84 bp [86,87].
Deletions were confirmed by PCR and sequencing from the
regions flanking the knockouts.
To obtain the vectors encoding ß-lactamase (TEM1) fusions all
genes were PCR-amplified from S. bongori strain 12419 genomic
DNA and PCR products digested and ligated into pCX340 [51] or
pRK5, respectively. If the KpnI restriction site of pCX340 was used a
new ribosome binding site (RBS) was included in the forward primer.
Sequence identity of the constructs was verified by DNA sequencing.
The pCX340 derivative plasmids were named pICC522 (fabI),
pICC523 (sboA), pICC524 (sboC), pICC525 (sboD), pICC526 (sboI)
and pICC527 (sboH), pICC611 (sopB), pICC612 (sopD).
To create a plasmid allowing the C-terminal fusion of four HA-
tags to the effectors, pCX340 was digested with EcoRI and XbaI to
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remove the tem1 gene. Subsequently an oligo cassette encoding
four HA-tags was ligated into the vector to give the plasmid
pICC613. PCR products of sboI and fabI and pICC613 were
digested and ligated as described for the vectors encoding TEM1
fusions to yield pICC614 (pSboI-HAx4) and pICC615 (pFabI-
HAx4). The plasmid pICC616 (pSboH) allowing the inducible
expression of untagged SboH was constructed by ligation of the
sboH PCR product in EcoRI and XbaI digested pCX340 and the
transfection vector pRK5-SboH (pICC548) by ligation of the PCR
product into pRK5 (Clontech). All pICC plasmids were used to
transform S. bongori strain 12419 wild type and mutant strains by
electroporation.
Translocation assay
The ß-lactamase (TEM1)-translocation assay for the identifi-
cation of translocated effector proteins was adapted from a
protocol previously described [51]. To obtain a confluent cell
layer 4.06104 HeLa cells were seeded in 200 mL DMEM (Sigma,
1000 mg/L glucose, supplemented with 10% fetal calf serum,
Glutamax (Invitrogen) and MEM non-essential amino acids
(Sigma)) growth medium per well of a black wall/clear-flat
bottom 96 well plate (Becton Dickinson) and cultured overnight.
Prior to infection the medium was replaced with 150 mL fresh
growth medium. Overnight LB broth cultures (6 mg/mL
tetracycline) of S. bongori strain 12419 or the DinvA mutant
carrying the pICC plasmids were diluted 1:30 in LB broth (6 mg/
mL tetracycline) and grown to an OD600 of 1.1–1.4 before
protein expression was induced by addition of 1 mM Isopropyl b-
D-1-thiogalactopyranoside (IPTG). The induced cultures were
incubated until an OD600 of 1.8–2.2 was reached and diluted in
Dulbecco’s-PBS (D-PBS, Sigma) to a concentration of 3.756108
bacteria/mL. To infect HeLa cells 20 mL bacterial dilution per
well was added and the infection was synchronized by
centrifugation (900 g, 5 min). After 1 h incubation at 37uC, 5%
CO2 the cell supernatant was replaced with 100 mL Hanks’
Buffered Salt Solution (Gibco, supplemented with 20 mM
HEPES, 3 mM Probenecid (Sigma) pH 7.4 designated HBSS-
HP), and 20 mL freshly prepared CCF2-AM ß-lactamase
substrate (LiveBLAzer FRET-B/G Loading Kit, Invitrogen) were
added. After 1 h 45 min incubation at room temperature in the
dark the cells were washed five times with HBSS-HP.
Fluorescence emission at 450 nm and 520 nm was measured
from the bottom using a Fluostar Optima plate reader (excitation
wavelength 410 nm, 10-nm band-pass). The translocation rate
was calculated as recommended in the LiveBLAzer FRET-B/G
Loading Kit manual. Briefly, emission values were first corrected
by subtraction of the average background signals recorded for
empty wells and the mean 450 nm/520 nm emission ratio of a
triplicate of wells was calculated for each sample. The
translocation rate is expressed as fold increase of the mean
emission ratio 450/520 nm of each infected sample in relation to
the mean emission ratio of uninfected cells. Expression of the
TEM1 fusion proteins was controlled by Western blot using a
mouse anti-ß-lactamase antibody (QED Bioscience Inc; data not
shown).
Epifluorescence microscopy of translocated effectors
HeLa cells (1.256105 per 24-well plate well) were seeded on
coverslips and incubated in growth media overnight in a
humidified atmosphere of 5% CO2 at 37 uC. S. bongori wild type
or DinvA mutant containing pICC614 or pICC614 plasmids were
grown, diluted and 50 mL dilution used for infection as described
for the translocation assay. 1 h45 min –2 h post infection cells
were washed three times with D-PBS, fixed with 3% paraformal-
dehyde (PFA), treated with 50 mM NH4Cl in D-PBS, washed
three times with D-PBS, permeabilised with 0.1% (v/v) Triton X-
100, washed three times with D-PBS and blocked with 2% (w/v)
bovine serum albumin (BSA) and 2% (v/v) natural donkey serum
in D-PBS for 1 h. The samples were stained with rabbit anti-
Salmonella (O:66 Statens Serum Institute) and mouse anti-HA.11
(Covance) primary antibodies followed by Rhodamine Red X
(RRX)-conjugated donkey anti-rabbit IgG and DyLight 488-
conjugated donkey anti-mouse IgG (both Jackson ImmunoRe-
search) antibodies. Nuclei were labelled with Hoechst 33342 dye
and F-actin with AlexaFluor647 phalloidin (Invitrogen). The
coverslips were mounted using ProLong Gold antifade reagent
(Invitrogen) and analysed on Zeiss Axio Imager Z1 or M1
immunofluorescence microscopes with Axiovision Rel 4.8 soft-
ware.
Epifluorescence microscopy and caspase-3 activation
assay
The experiments to compare the localization and anti-
apoptotic activity of NleH1 and SboH were performed as
described previously [52,88]. Briefly, transfected HeLa cells were
treated with either 5 mg/ml tunicamycin (TUN) or 10 mg/ml
brefeldin A (BFA) for 18 hours, or left untreated, prior to
immunofluorescence microscopy processing. The cells were fixed
in 3% PFA, washed with PBS, treated with 10 mM NH4Cl,
permeabilized with 0.2% (v/v) Triton X-100, washed with PBS
and blocked with 1% (v/v) BSA in PBS for 1 h. Active caspase-3
and Myc-tagged effector proteins were detected using rabbit anti-
cleaved caspase-3 (Cell Signalling Technology), RRX-conjugated
donkey anti-rabbit IgG (Jackson ImmunoResearch) and Fluores-
cein Isothiocyanate (FITC)-conjugated monoclonal mouse anti-
Myc (Sigma) antibodies. Nuclei were labelled with the Hoechst
33342 reagent (Invitrogen). Mitochondria were visualised using
MitoTracker (Invitrogen) in accordance with manufacturer’s
guidelines before fixation. Samples were mounted and analysed
by microscopy as described above. To determine the number of
apoptotic cells 100 transfected cells were analysed in each repeat.
Samples were tested in triplicate and experiments repeated a
minimum of three times.
Cell detachment assay
HeLa cells (7.26104 per 24-well plate well) were cultured
overnight. S. bongori wild type, DinvA,DsboH or DsboH pICC616
were grown for infection as described above. Prior infection 1 mL
bacterial culture was harvested by centrifugation, resuspended in
the same volume of cell culture medium and used to infect HeLa
cells. After 1 h cells were treated with 200 mg/ml gentamicin and
incubated for 4 h. A control sample was incubated with 1 mM
staurosporine (STS) for 5 h in parallel to the infection. Cells were
washed 5 times with PBS and then trypsinized for 10 min. Trypsin
was inactivated by addition of 700 mL growth medium. Cells were
counted on a Neubauer hemocytometer. All counts were
compared with the level of uninfected, untreated cells and plotted
as a percentage of cells lost. Statistical analysis was done using the
GraphPad InStat Version 3.06 software. The one-way ANOVA
Test using Bonferroni correction was used to determine signifi-
cance of the observed differences (p-values,0.001).
Accession numbers
The annotated genome sequence of Salmonella bongori strain 12419
has been deposited in the public databases under the accession
numbers FR877557. The Illumina sequencing reads for all the
sequences generated in this study have been deposited in the
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European Nucleotide Archive (ENA) under the accession numbers
ERS002029- ERS002042 (inclusive), ERS002044, ERS004246,
ERS004249, ERS004170, ERS004173- ERS004176 (inclusive),
ERS004190- ERS004193 (inclusive) and ERS004196. This is
matched to strain names in Table S1. Microarray data was
submitted to ArrayExpress under accession number E-TABM-931.
Supporting Information
Table S1 Details of the strains sequenced in this study, the
sequencing strategy, accession numbers and the estimated depth of
coverage.
(XLS)
Table S2 S. bongori mobile genetic element locations that were
excluded from phylogenetic tree.
(XLSX)
Table S3 Details of the plasmids and primers used in this study.
(XLS)
Table S4 Details of the individual pathways present or absent in
S. bongori strain 12419 and S. Typhi strains CT18.
(XLS)
Figure S1 Whole genome RAxML phylogeny for S. bongori
samples with strain labels. The tree is the same as that shown in
Figure 1, but showing strain labels and the numbers of SNPs that
separate each node on the tree. The two figures in brackets are
nodes where bootstrap support was less than 100%.
(TIF)
Figure S2 Genomic G+C content for representatives of E. coli,
Shigella flexneri and S. enterica and S. bongori.
(TIF)
Figure S3 ClustalW alignment of the protein sequences of SopA,
SboH and SboB showing the regions of conservation, see key.
(TIF)
Figure S4 ClustalW alignment of the protein sequences of SboH
and NleH orthologues. Systematic gene names are written down
the left. EPEC strain E2348/69, enterhemorrhagic E. coli strain
EDL933 and Citrobacter rodentium strain ICC168 systematic gene
names begin with E2348_, ECs_ and ROD_, respectively. The
regions of conservation are shown, see key.
(TIF)
Figure S5 ClustalW alignment of the protein sequences of SopA
from S. Typhimurium strains LT2 (SopA-LT2) and S. Enteritidis
strain P125109 (SopA-PT4) with SboA from S. bongori strain 12419
(SboA). Conserved ubiquitin protein ligases domain is shown, see
key.
(TIF)
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